tradingkey.logo
Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo
Search

Heron Therapeutics Inc

HRTX
Add to Watchlist
0.496USD
-0.001-0.24%
Close 07-31 16:00（ET）Quotes delayed by 15 min
93.57MMarket Cap
LossP/E TTM

Heron Therapeutics Inc

0.496
-0.001-0.24%
Overview
Financials
Discussions
Analysis
Company
Financial SummaryIncome StatementBalance SheetCash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial SummaryIncome StatementBalance SheetCash Flow Statement

HRTX Financials

See Heron Therapeutics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Heron Therapeutics Inc Earnings Date

Latest Release
Aug 10, 2026
EPS / Forecast
--/0.01
Revenue / Forecast
--/42.20M
See Upcoming Earnings >>
Period
FY2025 Earnings
Revenue(YoY)
154.90M
7.36%
EPS(YoY)
-0.12
-35.99%
Analyst Rating
BUY
2026/08/01
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
-349.10%-0.04
-606.44%-0.12
-223.77%-0.10
74.50%-0.02
182.15%0.02
133.75%0.02
81.61%-0.03
82.74%-0.06
92.39%-0.02
57.50%-0.07
---0.17
---0.35
---0.27
---0.17
----
----
----
----
----
----
Revenue
-10.78%34.71M
-0.47%40.59M
16.47%38.21M
3.26%37.20M
12.21%38.90M
19.13%40.78M
4.38%32.81M
13.42%36.02M
17.07%34.67M
14.00%34.23M
18.36%31.43M
14.95%31.76M
26.25%29.61M
45.38%30.03M
14.32%26.56M
23.11%27.63M
17.18%23.46M
0.24%20.66M
16.35%23.23M
-0.99%22.44M
Net Profit
-407.82%-8.11M
-180.64%-2.95M
-260.87%-17.50M
74.22%-2.38M
183.39%2.63M
134.16%3.66M
80.61%-4.85M
78.04%-9.23M
90.36%-3.16M
46.03%-10.72M
40.33%-25.01M
25.37%-42.06M
48.71%-32.77M
63.64%-19.87M
20.04%-41.91M
7.63%-56.36M
-21.43%-63.89M
12.26%-54.65M
10.00%-52.41M
-10.55%-61.02M
Net Margin
-444.99%-23.37%
-245.15%-13.04%
-209.85%-45.78%
75.03%-6.40%
174.31%6.77%
128.67%8.98%
81.43%-14.78%
80.64%-25.64%
91.76%-9.11%
52.66%-31.33%
---79.56%
---132.42%
---110.65%
---66.17%
----
----
----
----
----
----
Gross Margin
-11.38%69.35%
-2.15%73.31%
-3.30%68.82%
3.81%73.50%
3.46%78.26%
5.34%74.92%
69.16%71.17%
93.80%70.80%
75.55%75.64%
22.74%71.12%
--42.08%
--36.53%
--43.09%
--57.95%
----
----
----
----
----
----
Debt to assets ratio
-9.44%57.52%
-14.40%54.96%
-17.23%56.10%
10.08%75.49%
-7.45%63.52%
-4.43%64.21%
3.96%67.78%
-7.62%68.58%
1.51%68.63%
12.94%67.18%
--65.20%
--74.24%
--67.61%
--59.49%
----
----
----
----
----
----
Income Statement
Revenue
-10.78%34.71M
-0.47%40.59M
16.47%38.21M
3.26%37.20M
12.21%38.90M
19.13%40.78M
4.38%32.81M
13.42%36.02M
17.07%34.67M
14.00%34.23M
18.36%31.43M
14.95%31.76M
26.25%29.61M
45.38%30.03M
14.32%26.56M
23.11%27.63M
17.18%23.46M
0.24%20.66M
16.35%23.23M
-0.99%22.44M
Operating profit
-251.08%-4.76M
-99.09%38.00K
14.92%-3.79M
77.70%-1.44M
165.74%3.15M
140.83%4.17M
82.12%-4.46M
84.80%-6.45M
85.49%-4.80M
49.79%-10.22M
40.48%-24.93M
14.33%-42.40M
47.45%-33.06M
61.98%-20.36M
19.00%-41.88M
18.14%-49.50M
-20.74%-62.92M
12.66%-53.54M
11.43%-51.71M
-8.47%-60.47M
Net Profit
-407.82%-8.11M
-180.64%-2.95M
-260.87%-17.50M
74.22%-2.38M
183.39%2.63M
134.16%3.66M
80.61%-4.85M
78.04%-9.23M
90.36%-3.16M
46.03%-10.72M
40.33%-25.01M
25.37%-42.06M
48.71%-32.77M
63.64%-19.87M
20.04%-41.91M
7.63%-56.36M
-21.43%-63.89M
12.26%-54.65M
10.00%-52.41M
-10.55%-61.02M
Balance Sheet
Current assets
7.58%228.98M
13.90%238.07M
17.53%229.40M
10.33%210.92M
14.49%212.84M
10.72%209.01M
0.62%195.19M
15.66%191.17M
4.35%185.90M
-8.11%188.77M
-13.33%193.98M
-14.90%165.28M
-19.96%178.16M
-19.25%205.44M
-28.96%223.80M
-47.06%194.21M
-18.25%222.59M
-19.02%254.42M
-10.24%315.05M
-6.64%366.83M
Total current liabilities
2.21%90.52M
5.07%96.10M
4.87%89.71M
221.98%258.60M
17.48%88.56M
14.77%91.46M
7.27%85.54M
-7.39%80.32M
-3.24%75.38M
-3.24%79.69M
-15.05%79.75M
-20.80%86.72M
-16.24%77.90M
15.90%82.36M
29.85%93.88M
33.30%109.50M
-7.84%93.00M
-30.68%71.06M
-25.91%72.30M
-11.34%82.14M
Total assets
4.44%246.22M
9.75%255.88M
12.76%248.95M
6.40%232.09M
8.20%235.75M
4.78%233.15M
-3.67%220.78M
8.40%218.14M
-1.35%217.89M
-11.33%222.51M
-15.72%229.20M
-17.52%201.22M
-19.31%220.88M
-17.91%250.95M
-22.83%271.95M
-39.65%243.97M
-11.97%273.72M
-13.53%305.71M
-9.65%352.39M
-6.58%404.25M
Total liabilities
-10.27%237.08M
-9.47%241.54M
-10.24%234.06M
1.28%259.35M
4.99%264.20M
4.02%266.80M
1.48%260.78M
6.47%256.08M
8.33%251.65M
8.05%256.48M
3.00%256.99M
-9.48%240.51M
-6.99%232.31M
4.05%237.38M
6.83%249.50M
8.83%265.70M
117.74%249.76M
94.88%228.14M
106.90%233.54M
124.67%244.14M
Total equity
132.11%9.14M
142.59%14.33M
137.21%14.88M
28.15%-27.26M
15.73%-28.45M
0.95%-33.65M
-43.98%-40.01M
3.42%-37.94M
-195.44%-33.77M
-350.32%-33.97M
-223.77%-27.79M
-80.73%-39.28M
-147.70%-11.43M
-82.50%13.57M
-81.11%22.45M
-113.58%-21.74M
-87.79%23.96M
-67.20%77.57M
-57.12%118.84M
-50.59%160.11M
Cash Flow Statement
Net operating income
82.64%-1.54M
22.04%-9.18M
-60.52%1.33M
-136.06%-10.87M
6.79%-8.87M
-579.84%-11.78M
136.73%3.37M
83.05%-4.60M
61.78%-9.52M
106.54%2.46M
75.24%-9.18M
4.26%-27.16M
43.33%-24.90M
17.07%-37.53M
30.28%-37.07M
54.96%-28.37M
-4.77%-43.94M
13.88%-45.26M
-26.42%-53.17M
-9.98%-62.99M
Net investment
-141.31%-939.00K
-147.78%-5.46M
198.69%11.86M
258.11%7.33M
77.86%2.27M
229.22%11.42M
117.10%3.97M
-84.51%2.05M
-96.53%1.28M
-537.21%-8.84M
35.58%-23.22M
-33.09%13.22M
236.51%36.83M
108.33%2.02M
-266.62%-36.05M
-50.23%19.76M
351.98%10.95M
-142.72%-24.26M
-61.33%21.63M
22.49%39.70M
Net financing
-179.69%-51.00K
-48.23%219.00K
95350.00%13.36M
58.74%781.00K
481.82%64.00K
112.56%423.00K
-99.97%14.00K
54.23%492.00K
105.29%11.00K
-54.67%199.00K
-28.22%53.80M
1.27%319.00K
67.35%-208.00K
-9.86%439.00K
105652.11%74.94M
-99.80%315.00K
-172.14%-637.00K
-91.55%487.00K
-113.55%-71.00K
6592.43%154.73M

FAQs

What is the total revenue of Heron Therapeutics Inc?

According to Heron Therapeutics Inc's FY2025 earnings report, its total revenue reached 154.90M, with a year-on-year change of 144.28M.

What are the current assets of Heron Therapeutics Inc?

According to Heron Therapeutics Inc's FY2025 earnings report, its current assets were 238.07M, with a year-on-year change of 13.90.

What are the total assets of Heron Therapeutics Inc?

According to Heron Therapeutics Inc's FY2025 earnings report, its total assets of Heron Therapeutics Inc were 255.88M, with a year-on-year change of 9.75.

What are the total liabilities of Heron Therapeutics Inc?

According to Heron Therapeutics Inc's FY2025 earnings report, its total liabilities of Heron Therapeutics Inc were 241.54M, with a year-on-year change of -9.47.

What is the total equity of Heron Therapeutics Inc?

According to Heron Therapeutics Inc's FY2025 earnings report, its total equity of Heron Therapeutics Inc was 14.33M, with a year-on-year change of 142.59.

What is the net operating income of Heron Therapeutics Inc?

According to Heron Therapeutics Inc's FY2025 earnings report, its net operating income of Heron Therapeutics Inc was -2.54M, with a year-on-year change of 77.98.

What is the net investment of Heron Therapeutics Inc?

According to Heron Therapeutics Inc's FY2025 earnings report, its net investment of Heron Therapeutics Inc was 16.01M, with a year-on-year change of -14.45.

What is the net financing of Heron Therapeutics Inc?

According to Heron Therapeutics Inc's FY2025 earnings report, its net financing of Heron Therapeutics Inc was 14.43M, with a year-on-year change of 1434.79.

What is the Earnings Per Share (EPS) of Heron Therapeutics Inc?

According to Heron Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -0.12, with a year-on-year change of -35.99.

What is the net income of Heron Therapeutics Inc?

According to Heron Therapeutics Inc's FY2025 earnings report, its net income was -20.20M, with a year-on-year change of -48.71.

What is the net margin of Heron Therapeutics Inc?

According to Heron Therapeutics Inc's FY2025 earnings report, its net profit margin was -13.04, with a year-on-year change of -38.52.

What is the gross margin of Heron Therapeutics Inc?

According to Heron Therapeutics Inc's FY2025 earnings report, its gross margin was 73.31, with a year-on-year change of 0.13.

What is the debt-to-asset ratio of Heron Therapeutics Inc?

According to Heron Therapeutics Inc's FY2025 earnings report, its debt-to-asset ratio was 54.96, with a year-on-year change of -26.66.

What is the Return on Assets (ROA) of Heron Therapeutics Inc?

According to Heron Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -8.26, with a year-on-year change of -38.56.

What is the operating profit of Heron Therapeutics Inc?

According to Heron Therapeutics Inc's FY2025 earnings report, its operating profit was -2.54M, with a year-on-year change of 77.98.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.
General Terms of Use
Privacy Policy
Cookie Policy